The technologies used to map and sequence the human genome are also being used in leading research establishments to detect DNA mutations leading to genetic diseases such as muscular dystrophy, cystic fibrosis, HIV, and cancer susceptibility (1–3). The detection of mutations within many disease-related genes can be automated using fluorescent labeled fragments generated by PCR or cycle sequencing. One of Applied Biosystem’s main goals is to develop genetic analysis technologies to meet the needs of the clinical and research settings of the future